Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01977703 · ClinicalTrials.gov registry record · NA

Prospective Randomized Evaluation of an Ultra Conservative Approach to Implantable Defibrillator (ICD) Programming in Patients With a Left Ventricular Assist Device (LVAD).

A NA study, sponsored by Vanderbilt University Medical Center.

Completed
Registry status
NA
Development phase
80
Enrollment target

NCT01977703: Completed NA study, sponsored by Vanderbilt University Medical Center.

NCT01977703 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01977703, a NA study, has completed, sponsored by Vanderbilt University Medical Center.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target

Study Summary

We propose to study a strategy empirically applied for the past 6 months at a high volume LVAD center (Vanderbilt Heart and Vascular Institute). This utilizes an ultra conservative device programming strategy to maximize battery longevity, avoid inappropriate implantable cardioverter defibrillator (ICD) therapy, improve quality of life through reduction in overall shock burden, and potentially avoid unnecessary device generator changes prior to transplant. Avoiding CIED (cardiac implantable electronic device) change out device procedures prior to transplant is desirable.

Interventions

  • OTHER Ultra Conservative ICD Programming
  • OTHER Traditional ICD Programming

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2013-10
Est. Completion 2016-12
Phase NA

What the finished NCT01977703 record still lists

NCT01977703 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 2 interventions - of which Ultra Conservative ICD Programming is the first listed.

NCT01977703 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01977703 about?

NCT01977703 is a clinical study titled "Prospective Randomized Evaluation of an Ultra Conservative Approach to Implantable Defibrillator (ICD) Programming in Patients With a Left Ventricular Assist Device (LVAD).". We propose to study a strategy empirically applied for the past 6 months at a high volume LVAD center (Vanderbilt Heart and Vascular Institute). This utilizes an ultra conservative device programming strategy to maximize battery longevity, avoid inappropriate implantable cardioverter defibrillator (...

What is the current status of trial NCT01977703?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2013-10. Estimated completion is 2016-12.

What interventions are being tested in trial NCT01977703?

The interventions under investigation include: Ultra Conservative ICD Programming (OTHER), Traditional ICD Programming (OTHER).

Who is sponsoring clinical trial NCT01977703?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01977703's enrollment target sits among peer trials

80 994th of 2000 higher than 941 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01977703, the US trial registry maintained by the National Library of Medicine. NCT01977703 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.